The detection threshold for HPV positive status was set in accordance with the previously reported frequency of E6 gene copies per diploid genome for CaSki (869 copies)(22 (link)). Assuming an HPV16 driven tumour is composed of a dominant clonal population of cells, we scored as positive those samples with ≥1 E6 gene copy/diploid genome. A sample was only deemed positive if the threshold was met in both of the duplicate runs.
Bronchopneumonia
This type of pneumonia can be caused by a variety of infectious agents, including bacteria, viruses, and fungi.
Proper diagnosis and treatment are crucial to manage the condition and prevent complications.
Researchers can leverage PubCompare.ai to optimize their Bronchopneumonia studies, locating leading protocols from literature, preprints, and patents, and utilizing AI-driven comparisons to identify the best protocols and products.
This can enhance reproducibiity and accuaracy in Bronchopneumonia research, leading to more reliable and impactful findings.
Most cited protocols related to «Bronchopneumonia»
Macroscopic and microscopic pathology was assessed with standardized protocols as described (Kalaria et al., 2004 (link); Ihara et al., 2010 (link)). Briefly, macroscopic infarcts were detected by visual inspection while dissecting the brain, and their presence was subsequently confirmed by microscopy. Haematoxylin and eosin was used as standard stain for general neuropathological assessment of the structure of the brain, and for confirmation/detection of the infarcts. In this study, any infarct <5 mm in diameter was defined as a microinfarct. Gallyas and Bielschowsky's silver impregnation and tau immunohistochemistry were applied to assess neuritic plaques and neurofibrillary tangles for the ‘CERAD’ plaque score and ‘Braak and Braak’ neurofibrillary tangle staging. Additional staining included α-synuclein, ubiquitin and TDP-43 immunohistochemistry.
A clinical diagnosis of whether the dementia syndrome was present was made independently of neuropathological data prior to monthly clinicopathological consensus meetings where clinicians met with the pathologists to designate a final diagnosis for autopsied subjects. In all cases, additional pathologies such as Alzheimer's disease and dementia with Lewy bodies were noted. The pathological diagnosis of vascular dementia was then assigned if there was clinical evidence of dementia (DSM IV) and the presence of multiple or cystic infarcts involving cortical and subcortical structures, border-zone infarcts, lacunae, microinfarcts and small vessel disease in the general absence of a high burden of neurofibrillary pathology i.e. Braak staging
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Most recents protocols related to «Bronchopneumonia»
Example 5
To investigate whether a Canine/FL/04-like influenza virus had circulated among greyhound populations in Florida prior to the January 2004 outbreak, archival sera from 65 racing greyhounds were tested for the presence of antibodies to Canine/FL/04 using the HI and MN assays. There were no detectable antibodies in 33 dogs sampled from 1996 to 1999. Of 32 dogs sampled between 2000 and 2003, 9 were seropositive in both assays—1 in 2000, 2 in 2002, and 6 in 2003 (Table 5). The seropositive dogs were located at Florida tracks involved in outbreaks of respiratory disease of unknown etiology from 1999 to 2003, suggesting that a Canine/FL/04-like virus may have been the causative agent of those outbreaks. To investigate this possibility further, we examined archival tissues from greyhounds that died from hemorrhagic bronchopneumonia in March 2003. Lung homogenates inoculated into MDCK cells and chicken embryos from one dog yielded H3N8 influenza virus, termed A/Canine/Florida/242/2003 (Canine/FL/03). Sequence analysis of the complete genome of Canine/FL/03 revealed >99% identity to Canine/FL/04 (Table 4), indicating that Canine/FL/04-like viruses had infected greyhounds prior to 2004.
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
hematoxylin and eosin. Histologic scores and diagnoses were made by consensus
(LAJH or LS, and JLC) without knowledge of the gross diagnosis or microbiology
data. All lung sections were scored for the presence or absence of specified
histologic lesions (
and caudodorsal lung lesions was classified as acute (absence of fibrosis),
subacute (presence of immature granulation tissue), or chronic (presence of
mature fibrosis that was densely eosinophilic with fewer and smaller fibroblast
nuclei).
Histologic criteria for diagnosis of bronchopneumonia were neutrophils and
macrophages filling the lumen of alveoli and bronchioles. Histologic criteria
for alveolar and bronchiolar damage (a form of interstitial/bronchointerstitial
lung disease) were alveoli lined by hyaline membranes or type II pneumocytes and
loss of bronchiolar epithelium with attenuation of remaining epithelial cells,
respectively. Cases were diagnosed as BIP if bronchopneumonia was a predominant
histologic lesion in sections of cranioventral lung and alveolar and bronchiolar
damage were prominent in sections of caudodorsal lung. However, the lesion types
were not required to be anatomically segregated: The cranioventral lung sections
of some BIP cases had alveolar and bronchiolar damage in addition to the
bronchopneumonia required for the diagnosis of BIP, and the caudodorsal lung
sections of some BIP cases had bronchopneumonia in addition to the alveolar and
bronchiolar damage required for the diagnosis of BIP.
Top products related to «Bronchopneumonia»
More about "Bronchopneumonia"
This type of pneumonia can be caused by a variety of infectious agents, including bacteria (such as Streptococcus pneumoniae), viruses (such as influenza), and fungi (such as Pneumocystis jirovecii).
Symptoms of bronchopneumonia may include cough, fever, difficulty breathing, and chest pain.
Proper diagnosis and treatment are crucial to manage the condition and prevent complications, such as respiratory failure, sepsis, or acute respiratory distress syndrome (ARDS).
In research settings, bronchopneumonia studies often utilize cell lines like BEAS-2B (human bronchial epithelial cells) and techniques like collagenase I digestion, FBS supplementation, and 3-aminopropyltriethoxysilane coating to create in vitro models.
Researchers may also employ RPMI 1640 medium, Pentobarbital sodium anesthesia, and cell strainers to isolate and culture relevant cell types.
To optimize bronchopneumonia research, researchers can leverage tools like PubCompare.ai to locate leading protocols from the literature, preprints, and patents, and utilize AI-driven comparisons to identify the best protocols and products.
This can enhance reproducibilty and accuaracy in bronchopneumonia research, leading to more reliable and impactful findings, such as the development of novel therapeutic approaches or improved understanding of disease pathogenesis.